EU AI Act Readiness: A Structured Screening of 50 European AI Companies (April 2026)

Independent structured analysis of EU AI Act (Regulation (EU) 2024/1689) regulatory positioning across 50 European AI companies in HealthTech/MedTech, FinTech/InsurTech, HRTech/EdTech, and B2B SaaS/Industrial sectors, covering 15+ countries (FR, DE, BE, NL, PL, DK, CH, IE, UK, and others). Screening conducted between 10 and 12 April 2026.

Each company was screened against a 6-gate regulatory framework mapping to Articles 5, 6(1), 6(2) + Annex III, 50, 51/53, and 6(3) of the Regulation. The screening relied exclusively on publicly available information (company websites, CE mark disclosures, ACPR/ECB/MDR/IVDR filings, LinkedIn, press releases). No company was contacted and no confidential data was accessed. The 6-gate framework used in this screening is publicly documented at sprinklingact.com/methodology.

Key findings:

• 74% of screened companies trigger high-risk classification under Art. 6(1) or Art. 6(2) + Annex III
• 96% have no public AI Act regulatory position
• 44% have unaddressed Art. 50 transparency obligations
• 34% integrate GPAI models (Art. 3(63)) without documented Art. 50, Art. 26, or Art. 53 obligations
• 0 of 14 companies holding existing sectoral certifications (CE MDR, CE-IVD, ACPR banking licence) have mapped the additional AI Act layer
• 1 company raises an open question under Art. 5(1)(g) (biometric categorization in publicly accessible spaces)

The report includes aggregate results, sector breakdowns, five anonymized critical cases, a deployer cascade analysis under Art. 26, an enforcement timeline (with Art. 6(2) + Annex III obligations becoming applicable on 2 August 2026), and the full methodology. Sprinkling Act operates as a pre-conformity advisory firm in this market; no commercial relationship with any company listed existed at the time of this analysis.

This report is freely available to download, share, and reference with attribution.